Dr. Alvira Macanovic reports

VENTRIPOINT ANNOUNCES COLLABORATION WITH ASCEND CARDIOVASCULAR

Ventripoint Diagnostics Ltd. and Ascend Cardiovascular, a leading provider of cardiovascular IT (information technology) solutions, have solidified a strategic collaboration. The two companies have signed a letter of intent to explore joint research and development initiatives, knowledge sharing, and combining efforts to bring innovative AI-based (artificial intelligence) solutions to the market.

Ascend Cardiovascular has over two decades of experience in cardiovascular IT and is an expert in cardiology workflow. Ascend's clinical reporting, device interfaces and analytics are used daily by some of the top institutions and hospital systems in North America.

The teamwork between Ventripoint and Ascend leverages the strengths and expertise of both Ascend and Ventripoint to enhance cardiovascular diagnostics and improve patient care. By combining the capabilities of Ventripoint and Ascend, both companies aim to develop and integrate solutions to improve diagnostic accuracy, streamline workflows and enhance patient experience. Ascend intends to resell Ventripoint products developed through this partnership and integrated with Ascend's cardiovascular IT platform.

"This collaboration with Ascend Cardiovascular is part of Ventripoint's mission to elevate cardiac care by providing better tools for clinicians. We are excited about what the two companies can accomplish by joining efforts," stated Dr. Alvira Macanovic, president and chief executive officer of Ventripoint.

This co-ordination will include exploring joint research and development initiatives aimed at enhancing existing cardiovascular diagnostic technologies and identifying new opportunities.

This may include joint projects, knowledge sharing and collaborative efforts to seek regulatory approvals and commercialize new products or services, including, where applicable, co-marketing and sales support activities.

"Ascend is on a mission to provide a fully integrated, best-of-breed cardiovascular workflow solution to its customers. Integration with Ventripoint's innovative solution for 3-D visualization will provide tremendous value to pediatric and adult echocardiographers in the care of their most complex patients," stated Dr. Jeff Soble, chief executive officer of Ascend Cardiovascular.

Both Ventripoint and Ascend are excited about the potential impact of this collaboration within the field of cardiovascular diagnostics. Ascend brings its clinical and industry knowledge, along with its proprietary structured reporting, and its echocardiogram Dicom viewer to the collaboration. Ventripoint brings its proprietary AI-based diagnostic technologies, research capabilities and technical expertise in cardiovascular imaging and analysis. By combining the unique expertise and resources of both companies, new solutions can be made that address existing challenges within the industry.

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in the application of AI (artificial intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary KBR technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI (magnetic resonance imaging). This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide the company's future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the United States, Europe and Canada.

We seek Safe Harbor.